{
  "pmcid": "3008875",
  "sha256": "661e87d3a43e415c666bd912fecbfe20f4fa7eeab24771822ae0c9f0c83e173d",
  "timestamp_utc": "2025-11-09T23:46:58.241710+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.259700876740592,
    "reading_ease": 30.660385078219036,
    "word_count": 277
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Double-Blind Randomised Controlled Trial Comparing Minimally Invasive and Classic Approaches in Total Hip Arthroplasty"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to MIS or CLASS groups using a block-randomised, stratified method"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a single center, this double-blind, randomised controlled trial enrolled 120 patients eligible for primary noncemented THA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Minimally invasive surgery (MIS) for total hip arthroplasty (THA) is hypothesized to offer faster rehabilitation due to smaller incisions and reduced muscle dissection compared to the classic approach (CLASS)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the clinical outcomes of MIS versus CLASS."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the Harris Hip Score (HHS) at 6 weeks postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomly assigned to MIS or CLASS groups using a block-randomised, stratified method"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was maintained for patients and outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Conducted at a single center, this double-blind, randomised controlled trial enrolled 120 patients eligible for primary noncemented THA from January 2005 to November 2007."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "An intention-to-treat analysis was performed."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "At 6 weeks, the MIS group demonstrated a statistically significant increase in mean HHS compared to the CLASS group (mean difference = 4.5, 95% CI 0.5 to 8.5; p = 0.03)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included six complications in the MIS group and two in the CLASS group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}